Skip to main content

Bremelanotide (PT-141)

Meaning

Bremelanotide, also known by its research code PT-141, is a synthetic peptide medication used to treat generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It is an effective melanocortin receptor agonist that acts centrally within the brain, differentiating its action from traditional peripheral treatments for sexual dysfunction. Clinical practice utilizes this compound to address diminished libido, linking hormonal health directly to central nervous system function.